Health Care & Hospital Law
Oct. 10, 2023
Another lawsuit filed after FDA questions efficacy of oral decongestants
“For years, defendants have advertised and marketed the phenylephrine products to unsuspecting consumers despite knowing that phenylephrine is ineffective for the treatment of nasal congestion and the other cold and flu symptoms for which defendants promote its use,” plaintiffs’ attorneys Christopher R. Rodriguez and Andrew D. Bluth of Singleton Schreiber LLP wrote in the complaint.
Manufacturers and sellers of common over-the-counter decongestants – including Sudafed, Tylenol, Nyquil, Theraflu and Mucinex – are accused of fraud following an FDA finding that they are not effective in their oral form.
What is believed to be the first lawsuit following the FDA announcement was filed four weeks ago in the Eastern District of California. Pack et al. v. Johnson & Johnson Consumer Companies Inc. et al., 23-cv-01965, (E....
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In